News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
29,719 Results
Type
Article (3017)
Company Profile (5)
Press Release (26697)
Multimedia
Podcasts (6)
Webinars (2)
Section
Business (9627)
Career Advice (213)
Deals (1443)
Drug Delivery (7)
Drug Development (3595)
Employer Resources (13)
FDA (786)
Job Trends (902)
News (15756)
Policy (1483)
Tag
Academia (109)
Allergies (3)
Alliances (2307)
ALS (2)
Alzheimer's disease (26)
Antibody-drug conjugate (ADC) (1)
Approvals (787)
Artificial intelligence (7)
Bankruptcy (6)
Best Places to Work (554)
Biosimilars (2)
Biotechnology (2)
Brain cancer (3)
Breast cancer (3)
Cancer (54)
Cardiovascular disease (6)
Career advice (166)
Career pathing (1)
CAR-T (1)
Cell therapy (7)
Cervical cancer (1)
Clinical research (2982)
Collaboration (18)
Compensation (3)
COVID-19 (193)
CRISPR (1)
C-suite (18)
Cystic fibrosis (3)
Data (57)
Denatured (6)
Depression (1)
Diabetes (2)
Diagnostics (238)
Diversity, equity & inclusion (3)
Drug discovery (2)
Drug pricing (5)
Drug shortages (1)
Duchenne muscular dystrophy (6)
Earnings (2190)
Editorial (2)
Employer branding (5)
Employer resources (12)
Events (3418)
Executive appointments (53)
FDA (815)
Funding (20)
Gene editing (3)
Generative AI (1)
Gene therapy (7)
GLP-1 (28)
Government (183)
Guidances (2)
Healthcare (847)
Immunology and inflammation (1)
Infectious disease (196)
Inflammatory bowel disease (6)
Inflation Reduction Act (4)
Interviews (55)
IPO (411)
IRA (4)
Job creations (371)
Job search strategy (132)
Layoffs (40)
Leadership (1)
Legal (479)
Liver cancer (2)
Lung cancer (6)
Lymphoma (6)
Management (4)
Manufacturing (4)
MASH (1)
Medical device (518)
Medtech (518)
Mergers & acquisitions (1050)
Metabolic disorders (5)
Neurodegenerative disease (1)
Neuropsychiatric disorders (1)
Neuroscience (32)
NextGen: Class of 2025 (368)
Non-profit (242)
Now hiring (1)
Obesity (2)
Opinion (32)
Ovarian cancer (2)
Pain (6)
Pancreatic cancer (1)
Parkinson's disease (2)
Partnered (1)
Patents (3)
Patient recruitment (4)
Peanut (3)
People (4443)
Pharmaceutical (2)
Phase I (852)
Phase II (1244)
Phase III (1179)
Pipeline (34)
Policy (7)
Postmarket research (181)
Preclinical (275)
Press Release (5)
Prostate cancer (1)
Psychedelics (1)
Radiopharmaceuticals (6)
Rare diseases (14)
Real estate (280)
Recruiting (5)
Regulatory (905)
Research institute (105)
Resumes & cover letters (36)
RSV (2)
Series A (2)
Series B (3)
Sickle cell disease (2)
Startups (264)
Supply chain (2)
Vaccines (54)
Women's health (1)
Worklife (1)
Date
Today (1)
Last 7 days (21)
Last 30 days (70)
Last 365 days (905)
2025 (344)
2024 (950)
2023 (1223)
2022 (2685)
2021 (2614)
2020 (2251)
2019 (2066)
2018 (1576)
2017 (1378)
2016 (1317)
2015 (1835)
2014 (1279)
2013 (1063)
2012 (1073)
2011 (1261)
2010 (1207)
Location
Africa (90)
Arizona (8)
Asia (1233)
Australia (362)
California (147)
Canada (42)
China (8)
Colorado (12)
Connecticut (5)
Delaware (4)
Europe (6020)
Florida (26)
Georgia (3)
Idaho (1)
Illinois (14)
Indiana (11)
Japan (11)
Louisiana (1)
Maryland (19)
Massachusetts (141)
Michigan (3)
Minnesota (9)
Missouri (1)
Nebraska (6)
Nevada (1)
New Jersey (78)
New Mexico (1)
New York (51)
North Carolina (35)
Northern California (80)
Ohio (1)
Oregon (1)
Pennsylvania (53)
Rhode Island (1)
South America (79)
South Carolina (1)
Southern California (39)
Texas (10)
United States (649)
Utah (1)
Virginia (3)
Washington D.C. (4)
Washington State (14)
Wisconsin (3)
29,719 Results for "smi".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
ScienceMedia’s SMi Trial™ Receives Heightened Interest for Supporting Diversity and Inclusion in Clinical Trials for Underrepresented Populations
SMi Trial™, ScienceMedia’s protocol compliance and risk-based training for clinical trials, is receiving outstanding praise from sponsors for their recently added training materials on recruiting diverse and underrepresented patient populations.
August 22, 2023
·
3 min read
BioForest
NanoString’s CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution
NanoString Technologies, Inc. announced the release of the first public dataset of the whole transcriptome obtained at true single-cell resolution on the CosMx™ Spatial Molecular Imager.
January 7, 2024
·
6 min read
OliX Pharmaceuticals to Present at SMi 13th Annual RNA Therapeutics Conference
OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, announced that the Company’s management will present at the SMi 13th Annual RNA Therapeutics Conference taking place virtually February 9-10, 2022.
February 7, 2022
·
1 min read
Biotech Beach
SMi Trial™ “Closes the Loop” by Confronting One of the Biggest Problems in Clinical Trials
ScienceMedia announces that SMi Trial’s fully mobile, fully compatible, just-in-time solution closes the loop in clinical trials. Clinical trials are embedded in a clinical process of humans caring for humans.
July 14, 2021
·
2 min read
Business
ScienceMedia’s SMi Trial Launches Significant Updates and Expands Team
ScienceMedia, the leader in life sciences and clinical trial education, has again demonstrated its commitment to innovation by launching a new version of SMi Trial , the company’s risk-based protocol training solution, and expanding the ScienceMedia team with the addition of a new Product Director, Robert Geckeler
March 3, 2021
·
3 min read
BioMidwest
Exicure to Present at SMi’s RNA Therapeutics 2019 Conference
Exicure, Inc., the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid constructs, announced that its CEO, Dr. David Giljohann, will present at SMi’s RNA Therapeutics 2019 Conference being held February 20-21, 2019 at the Copthorne Tara Hotel in London, UK.
February 18, 2019
·
3 min read
Biotech Beach
ScienceMedia Breaks Down Barriers to Bringing More Diverse Patient Populations to Clinical Trials
SMi Trial™, ScienceMedia’s protocol compliance and risk-based training solution for clinical trials, now supports diversity in clinical trials.
February 6, 2023
·
3 min read
Pharm Country
Soterix Medical Announces Patient Recruitment for Parcel-Guided rTMS Depression Trial
Soterix Medical Inc. (SMI), a global leader in non-invasive stimulation and synergistic brain monitoring technologies, announced today that patient recruitment for its treatment resistant depression trial funded by National Institute of Health has begun in New York City.
May 8, 2023
·
2 min read
Biotech Beach
Registration opens for SMi’s 4th Pre-filled Syringes West Coast 2019
Building on last year’s success SMi Group are proud to present the 4th Pre-filled Syringes West Coast 2019 Conference and exhibition in CA, USA
March 13, 2019
·
2 min read
BioForest
NanoString Showcases Ultra High-Plex 6K RNA Single Cell Imaging at the 2023 Advances in Genome Biology and Technology (AGBT)
NanoString Technologies, Inc. today announced an update to the technology roadmap for the CosMx™ Spatial Molecular Imager (SMI) that will be presented at the 2023 Advances in Genome Biology and Technology General Meeting in Hollywood, FL.
February 6, 2023
·
4 min read
1 of 2,972
Next
